Advisor Group Holdings, Inc. Bei Gene, Ltd. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 938 shares of BGNE stock, worth $205,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares

938

Previous 1,076 12.83%

Holding current value

$205,140

Previous $153,000 37.25%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$143.93 - $224.51 $19,862 - $30,982	-138 Reduced 12.83%	938 $210,000
Q2 2024 Aug 13, 2024	BUY	$129.52 - $174.32 $49,476 - $66,590	382 Added 55.04%	1,076 $153,000
Q1 2024 May 10, 2024	SELL	$141.8 - $181.47 $170,443 - $218,126	-1,202 Reduced 63.4%	694 $108,000
Q4 2023 Feb 12, 2024	SELL	$158.67 - $201.58 $51,250 - $65,110	-323 Reduced 14.56%	1,896 $341,000
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $92,633 - $115,941	515 Added 30.22%	2,219 $399,000
Q2 2023 Aug 10, 2023	BUY	$178.3 - $266.78 $7,310 - $10,937	41 Added 2.47%	1,704 $303,000
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $41,812 - $53,253	-194 Reduced 10.45%	1,663 $358,000
Q4 2022 Feb 10, 2023	BUY	$125.51 - $229.3 $45,685 - $83,465	364 Added 24.38%	1,857 $408,000
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $5,667 - $8,696	43 Added 2.97%	1,493 $201,000
Q2 2022 Aug 10, 2022	BUY	$121.11 - $216.05 $17,318 - $30,895	143 Added 10.94%	1,450 $235,000
Q1 2022 May 04, 2022	BUY	$146.52 - $269.56 $36,630 - $67,390	250 Added 23.65%	1,307 $317,000
Q3 2021 Nov 05, 2021	SELL	$249.6 - $403.14 $27,955 - $45,151	-112 Reduced 9.58%	1,057 $383,000
Q2 2021 Aug 02, 2021	BUY	$292.75 - $367.01 $80,799 - $101,294	276 Added 30.91%	1,169 $401,000
Q1 2021 May 13, 2021	BUY	$260.64 - $382.12 $44,569 - $65,342	171 Added 23.68%	893 $310,000
Q4 2020 Feb 10, 2021	SELL	$221.31 - $316.61 $5,532 - $7,915	-25 Reduced 3.35%	722 $186,000
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $31,214 - $47,262	165 Added 28.35%	747 $213,000
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $371 - $586	-3 Reduced 0.51%	582 $110,000
Q1 2020 May 18, 2020	BUY	$121.84 - $173.19 $71,276 - $101,316	585 New	585 $72,000

Others Institutions Holding BGNE

# of Institutions

253

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Bei Gene, Ltd. Transaction History